China NMPA Product Recall - Disposable end-to-end stapler

On February 18, 2020, Covidien Medical Devices Manufacturing (Shanghai) Co., Ltd. proactively initiated a voluntary Class III recall for its disposable end-to-end anastomosing devices. This significant regulatory action, published by the National Medical Products Administration (NMPA) and further detailed on the Shanghai Municipal Drug Administration website, was undertaken due to identified discrepancies. Specifically, the products were found to be inconsistent with certain technical requirements outlined for domestically registered and approved medical devices in China. The affected devices, identified by Registration Certificate No.: "沪械注准20192020076", necessitated this recall to address the potential impact of these deviations on product performance or safety. While the document specifies a Class III recall, indicating a situation where the use of the product is unlikely to cause adverse health consequences, the company's voluntary action underscores its commitment to product integrity and regulatory compliance. Further comprehensive information regarding specific models, specifications, and affected batch numbers is available in the detailed 'Medical Device Recall Event Report Form'. This measure ensures that all products distributed meet the stringent quality and safety standards mandated by Chinese medical device regulations.